Cargando…
Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265662/ https://www.ncbi.nlm.nih.gov/pubmed/32487139 http://dx.doi.org/10.1186/s13054-020-03014-1 |
| _version_ | 1783541170933071872 |
|---|---|
| author | Cour, Martin Ovize, Michel Argaud, Laurent |
| author_facet | Cour, Martin Ovize, Michel Argaud, Laurent |
| author_sort | Cour, Martin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7265662 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72656622020-06-02 Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? Cour, Martin Ovize, Michel Argaud, Laurent Crit Care Editorial BioMed Central 2020-06-02 /pmc/articles/PMC7265662/ /pubmed/32487139 http://dx.doi.org/10.1186/s13054-020-03014-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Editorial Cour, Martin Ovize, Michel Argaud, Laurent Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| title | Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| title_full | Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| title_fullStr | Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| title_full_unstemmed | Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| title_short | Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| title_sort | cyclosporine a: a valid candidate to treat covid-19 patients with acute respiratory failure? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265662/ https://www.ncbi.nlm.nih.gov/pubmed/32487139 http://dx.doi.org/10.1186/s13054-020-03014-1 |
| work_keys_str_mv | AT courmartin cyclosporineaavalidcandidatetotreatcovid19patientswithacuterespiratoryfailure AT ovizemichel cyclosporineaavalidcandidatetotreatcovid19patientswithacuterespiratoryfailure AT argaudlaurent cyclosporineaavalidcandidatetotreatcovid19patientswithacuterespiratoryfailure |